A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In response to tenacious stress signals, such as the unscheduled activation of oncogenes, cells can mobilize tumour suppressor networks to avert the hazard of malignant transformation. A large body of evidence indicates that oncogene-induced senescence (OIS) acts as such a break, withdrawing cells from the proliferative pool almost irreversibly, thus crafting a vital pathophysiological mechanism that protects against cancer. Despite the widespread contribution of OIS to the cessation of tumorigenic expansion in animal models and humans, we have only just begun to define the underlying mechanism and identify key players. Although deregulation of metabolism is intimately linked to the proliferative capacity of cells, and senescent cells are thought to remain metabolically active, little has been investigated in detail about the role of cellular metabolism in OIS. Here we show, by metabolic profiling and functional perturbations, that the mitochondrial gatekeeper pyruvate dehydrogenase (PDH) is a crucial mediator of senescence induced by BRAF(V600E), an oncogene commonly mutated in melanoma and other cancers. BRAF(V600E)-induced senescence was accompanied by simultaneous suppression of the PDH-inhibitory enzyme pyruvate dehydrogenase kinase 1 (PDK1) and induction of the PDH-activating enzyme pyruvate dehydrogenase phosphatase 2 (PDP2). The resulting combined activation of PDH enhanced the use of pyruvate in the tricarboxylic acid cycle, causing increased respiration and redox st…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondria in senescentcellsarelessfunctional,showingdecreasedmembrane potential, increased proton leak, reduced fusion and fission rates, increased mass, and abundance of tricarboxylic acid (TCA) cycle metabolites (Kaplon et al., 2013; Passos et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kaplon et al., 2013
In the citing paper
“Senescent cells exhibit several changes in mitochondrial function, dynamics, and morphology.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kaplon et al., 2013
In the citing paper
“Targeting aspects of mitochondrial biology, such as the electron transport chain (ETC), complex I assembly, mitochondrial fission rates, and biogenesis, mitochondrial sirtuins and/or disruption of the TCA cycle can trigger senescence (Correia-Melo et al., 2016; Jiang et al., 2013; Kaplon et al., 2013; Miwa et al., 2014; Moiseeva et al., 2009; Park et al., 2010; Wiley et al., 2016).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kaplon et al., 2013
In the citing paper
“In addition to the active protein metabolism described above, recent reports have shown that mitochondrial oxidative metabolism is up-regulated in senescent cells to support the metabolic demands of these cells (Dörr et al. 2013; Kaplon et al. 2013).”
From Cellular senescence and its effector programs (2014) · cites this paper as Kaplon et al. 2013
In the citing paper
“This revealed that pyruvate dehydrogenase (PDH) plays a key role in OIS.”
From Cellular senescence and its effector programs (2014) · cites this paper as Kaplon et al. 2013
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Self-citationThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Self-citationFantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711741105 · Cited by 1,346
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Cited by
Items 301–400 of 653
O’Hara, S. P., Splinter, P. L., Trussoni, C. E., Pisarello, M. J. L., Loarca, L., Splinter, N. S., Schutte, B. F., & LaRusso, N. F. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.777409 · Cited by 36
The molecular mechanism of aging and the role in neurodegenerative diseases
Zhao, J., Han, Z.-J., Ding, L., Wang, P., He, X., & Li, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24751 · Cited by 43
“The decrease in mitochondrial function is indicated by decreased membrane potential, increased proton leakage, decreased fusion and division rates, and increased mass and the variety of tricarboxylic acid cycle metabolites [42].”
BackgroundMitochondrial Ca2+ Remodeling is a Prime Factor in Oncogenic Behavior
Rimessi, A., Patergnani, S., Bonora, M., Wieckowski, M. R., & Pinton, P. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00143 · Cited by 38
“Recently, the mitochondrial gatekeeper PDH was shown to be a crucial mediator of oncogene-induced senescence promoted by BRAF (V600E), which is the oncogene that is commonly mutated in tumors (30).”
BackgroundZhang, N., Sun, L., Zhou, S., Ji, C., Cui, T., Chu, Q., Ye, J., Liang, S., Ma, K., Liu, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58429-7 · Cited by 34
“PDHA1 catalyzes the conversion of pyruvate to acetyl-CoA, thereby linking glycolysis with the TCA cycle 14,15 .”
Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma
Gutteridge, R. E. A., Singh, C. K., Ndiaye, M. A., & Ahmad, N. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.013 · Cited by 35
Hexokinase II promotes the Warburg effect by phosphorylating alpha subunit of pyruvate dehydrogenase
Luo, F., Li, Y., Yuan, F., & Zuo, J. (2019) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2019.03.14 · Cited by 37
The double inhibition of PDK1 and STAT3-Y705 prevents liver metastasis in colorectal cancer
Qin, W., Tian, Y., Zhang, J., Liu, W., Zhou, Q., Hu, S., Yang, F., Li, L., Lu, H., Cui, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49480-8 · Cited by 36
Dissecting cellular senescence and SASP in Drosophila
Ito, T., & Igaki, T. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0031-4 · Cited by 36
“A recent study in human cell cultures has indicated that Ras cells show elevated mitochondrial respiration via enhanced conversion of pyruvate to acetyl-CoA that is the origin of mitochondrial tricarboxylic acid (TCA) cycle [56].”
Recent Advances in Metabolic Profiling and Imaging of Prostate Cancer
Thapar, R., & Titus, M. A. (2014) · Current Metabolomics · doi:10.2174/2213235x02666140301002510 · Cited by 36
Martínez, J., Tarallo, D., Palma, L. M., Victoria, S., Bresque, M., Rodríguez-Bottero, S., Marmisolle, I., Escande, C., Cassina, P., Casanova, G., et al. (2019) · Biochemical Journal · doi:10.1042/bcj20190405 · Cited by 36
Pyruvate dehydrogenase kinase is a negative regulator of interleukin-10 production in macrophages
Na, Y. R., Jung, D., Song, J., Park, J., Hong, J. J., & Seok, S. H. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz113 · Cited by 36
“The different effects of PDK and LDH inhibition were most obvious in cytokine production because Fx11 inhibited the synthesis of IL10 (Supplementary Figure S4A and B).”
BackgroundInfluentialArrangement and symmetry of the fungal E3BP-containing core of the pyruvate dehydrogenase complex
Forsberg, B. O., Aibara, S., Howard, R. J., Mortezaei, N., & Lindahl, E. R. (2020) · Nature Communications · doi:10.1038/s41467-020-18401-z · Cited by 35
Supper, E., Rudat, S., Iyer, V., Droop, A., Wong, K., Spinella, J.-F., Thomas, P., Sauvageau, G., Adams, D. J., & Wong, C. C. (2021) · Nature Communications · doi:10.1038/s41467-021-22750-8 · Cited by 35
Barros, P. R., Costa, T. J. D., Akamine, E. H., & Tostes, R. C. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.727604 · Cited by 34
Xie, Y., Wang, H., Cheng, X., Wu, Y. C., Cao, L., Wu, M., Xie, W., Wang, G., & Hao, H. (2016) · Scientific Reports · doi:10.1038/srep18751 · Cited by 35
The Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
Metabolic modulation of cancer: a new frontier with great translational potential
Kinnaird, A. S., & Michelakis, E. D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1250-2 · Cited by 33
“In addition, inhibition of PDK using RNA interference has recently been shown to promote oncogene-induced senescence in melanoma in vitro and in vivo, providing another mechanism through which DCA may be exerting antitumor effects [120].”
p53 and regulation of tumor metabolism
Yang, X., Jiang, P., & Du, W. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.122760 · Cited by 36
Metabo-Devo: A metabolic perspective of development
Gándara, L., & Wappner, P. (2018) · Mechanisms of Development · doi:10.1016/j.mod.2018.02.004 · Cited by 33
Indini, A., Fiorilla, I., Ponzone, L., Calautti, E., & Audrito, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179985 · Cited by 33
Targeting respiratory complex I to prevent the Warburg effect
Vatrinet, R., Iommarini, L., Kurelac, I., Luise, M. D., Gasparre, G., & Porcelli, A. M. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.017 · Cited by 33
Trinidad, A. G., Whalley, N., Rowlinson, R. A., Delpuech, O., Dudley, P., Rooney, C., & Critchlow, S. E. (2017) · Oncogene · doi:10.1038/onc.2017.224 · Cited by 33
Palmer, C. S., Palchaudhuri, R., Albargy, H. A., Abdel‐Mohsen, M., & Crowe, S. M. (2018) · F1000Research · doi:10.12688/f1000research.11881.1 · Cited by 34
Li, W., & Wang, J. (2020) · iScience · doi:10.1016/j.isci.2020.101002 · Cited by 30
Metabolic dysfunction and inflammatory disease: the role of stromal fibroblasts
Farah, H., Young, S. P., Mauro, C., & Jones, S. W. (2020) · FEBS Journal · doi:10.1111/febs.15644 · Cited by 35
Takenaka, Y., Inoue, I., Nakano, T., Ikeda, M., & Kakinuma, Y. (2021) · FEBS Journal · doi:10.1111/febs.16249 · Cited by 33
Targeting Mitochondria to Control Ageing and Senescence
Protasoni, M., & Serrano, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020352 · Cited by 31
Liu, W., Zhu, P., Li, M., Li, Z., Yu, Y., Liu, G., Du, J., Wang, X., Yang, J., Tian, R., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112740 · Cited by 35
13C MRS and LC–MS Flux Analysis of Tumor Intermediary Metabolism
Shestov, A. A., Lee, S., Nath, K., Guo, L., NELSON, D. S., Roman, J. C., Leeper, D. B., Wasik, M. A., Blair, I. A., & Glickson, J. D. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00135 · Cited by 33
Stem cell mitochondria during aging
Min‐Wen, J. C., Jun‐Hao, E. T., & Shyh‐Chang, N. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.02.005 · Cited by 29
“In contrast, the oncogene RAS and the downstream RAF increase mitochondrial ROS to cause oncogene-induced senescence, a mechanism thought to act as a break to irreversibly withdraw proliferative cells from the cell-cycle and prevent malignant transformation into cancer cells.”
InfluentialTargeting Aging: Lessons Learned From Immunometabolism and Cellular Senescence
Martin, D. E., Torrance, B. L., Haynes, L., & Bartley, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714742 · Cited by 32
Mitochondrial function in melanoma
Theodosakis, N., Micevic, G., Kelly, D. P., & Bosenberg, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.028 · Cited by 35
Liu, X., Zuo, R.-J., Bao, Y., Qu, X., Sun, K., & Ying, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-09163-8 · Cited by 43
Yang, L. C., You, J., Yang, X., Jiao, R., Xu, J., Zhang, Y., Mi, W., Zhu, L., Ye, Y., Ren, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57334-3 · Cited by 30
“Histone acetylation on SASP gene super-enhancers and enhancers featured by lysine 27 acetylated histone H3 (H3K27ac), and the interaction with transcription factor NF κ B, play pivotal roles in the activation of SASP gene transcription 45,46 .”
The role of thioredoxin reductase 1 in melanoma metabolism and metastasis
Cassidy, P. B., Honeggar, M., Poerschke, R. L., White, K. H., Florell, S. R., Andtbacka, R. H. I., Tross, J., Anderson, M., Leachman, S. A., & Moos, P. J. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12398 · Cited by 30
“Data from the laboratory of Daniel Peeper (Kaplon et al., 2013) demonstrate that transfection of human dermal fibroblasts with activated BRAFV600E induces OIS and that senescence requires the activation of mitochondrial gatekeeper pyruvate dehydrogenase (PDH).”
BackgroundCipolleschi, M. G., Marzi, I., Santini, R., Fredducci, D., Vinci, M. C., D’Amico, M., Rovida, E., Stivarou, T., Torre, E., Sbarba, P. D., et al. (2013) · Cell Cycle · doi:10.4161/cc.27031 · Cited by 28
“…in view of the fact that PDH, a gatekeeper linking glycolysis to oxidative metabolism, acts a potent barrier against malignant transformation (Kaplon et al., 2013).16 Both blockade and saturation impair the shuttle mechanisms, which transport the reducing equivalents generated by the…”
BackgroundWang, G., Liu, X., Xie, J., Meng, J., & Ni, X. (2019) · Bioscience Reports · doi:10.1042/bsr20182099 · Cited by 28
Senotherapeutics in Cancer and HIV
Sánchez-Díaz, L., Espinosa-Sánchez, A., Blanco, J. R., & Carnero, A. (2022) · Cells · doi:10.3390/cells11071222 · Cited by 29
Moretti, D. N., Peselj, C., Taşkin, A. A., Myketin, L., Schulte, U., Einsle, O., Drepper, F., Luzarowski, M., & Vögtle, F. ‐. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.02.011 · Cited by 27
Shining a light on metabolic vulnerabilities in non-small cell lung cancer
Dowling, C. M., Zhang, H., Chonghaile, T. N., & Wong, K.-K. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188462 · Cited by 26
Hyperoside protects cardiomyocytes against hypoxia‑induced injury via upregulation of microRNA‑138
He, S., Yin, X., Wu, F., Zeng, S., Gao, F., Xin, M., Wang, J., Chen, J., Zhang, L., & Zhang, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11925 · Cited by 26
“PDK1 is an essential enzyme involved in glucose metabolism that promotes gluconeogenesis from pyruvate, lactic acid and alanine (34), and prevents the incorporation of pyruvate in the oxidative phosphorylation process, leading to enhanced anaerobic glycolysis and decreased cellular respiration (11,35).”
BackgroundMitochondrial Dysfunction and Disturbed Coherence: Gate to Cancer
Pokorný, J., Pokorný, J., Foletti, A., Kobilková, J., Vrba, J., & Vrba, J. (2015) · Pharmaceuticals · doi:10.3390/ph8040675 · Cited by 33
“Oncogene mutations may result in mitochondrial dysfunction [54].”
BackgroundApoptotic transition of senescent cells accompanied with mitochondrial hyper-function
Wang, D., Liu, Y., Zhang, R., Zhang, F., Sui, W., Chen, L., Zheng, R., Chen, X., Wen, F., Ouyang, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8536 · Cited by 28
“In addition, studies have also reported the implication of mitochondrial metabolism enzymes like malic enzymes (ME1/2) [20], malate dehydrogenase (MDH1) [21] and pyruvate dehydrogenase (PDH) [22] in cellular senescence.”
Drug-induced premature senescence model in human dental follicle stem cells
Zhai, Y., Wei, R., Liu, J., Wang, H., Cai, W., Zhao, M., Hu, Y., Wang, S., Yang, T., Liu, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14085 · Cited by 26
“BRAF (V600E), also DDR-independent protein, triggers cell ageing by a metabolic machinery involving upregulation of mitochondrial pyruvate dehydrogenase [33].”
BackgroundGuo, X. Q., Niemi, N. M., Coon, J. J., & Pagliarini, D. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.787341 · Cited by 27
α‐Lipoic Acid Targeting PDK1/NRF2 Axis Contributes to the Apoptosis Effect of Lung Cancer Cells
Yue, L., Ren, Y., Yue, Q., Ding, Z., Wang, K., Zheng, T., Chen, G., Chen, X., Li, M., & Fan, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6633419 · Cited by 26
“PDK1, as a gatekeeping gene that assists in regulating the PDH activity, is the regulator for the PDH activity [33].”
BackgroundPyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma
Davidson, S. M., Heyman, J. E., O’Brien, J. P., Liu, A. C., Schmidt, D. R., Israelsen, W. J., Dayton, T. L., Sehgal, R., Bronson, R. T., Freinkman, E., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2352 · Cited by 30
Goyal, M., Tomar, A., Madhwal, S., & Mukherjee, T. (2021) · Development · doi:10.1242/dev.199550 · Cited by 25
Shang, J., Lin, N., Peng, R., Jiang, N., Wu, B., Xing, B., Lin, S., Xu, X., & Lu, H. (2023) · Molecules · doi:10.3390/molecules28030924 · Cited by 27
“Dysfunctional mitochondria, characterized by disrupted membrane potential, increased production of superoxide anions and hydrogen peroxide, and decreased ATP production, have been identified as the primary cause of senescence and SASP generation [20,40,41].”
BackgroundChen, Y., Yang, Z., Bai, J., Wang, X., Yuan, Q., Mi, Y., & Zhang, C. (2024) · Antioxidants · doi:10.3390/antiox13030377 · Cited by 27
“This dysfunction is evidenced by decreased membrane potential, heightened electron leakage, and impaired rates of fusion and division [14].”
BackgroundZhang, W., Hu, X., Zhou, W., & Tam, K. Y. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00184 · Cited by 26
Zhuang, Y., Ly, R. C., Frazier, C., Yu, J., Qin, S., Fan, X., Goetz, M. P., Boughey, J. C., Weinshilboum, R. M., & Wang, L. (2019) · Cancer & Metabolism · doi:10.1186/s40170-018-0193-4 · Cited by 25
Gándara, L., Durrieu, L., Behrensen, C., & Wappner, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-56446-3 · Cited by 26
Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells
You, R., Dai, J., Zhang, P., Barding, G. A., & Raftery, D. (2018) · Metabolites · doi:10.3390/metabo8040095 · Cited by 24
“The mitochondrial gatekeeper pyruvate dehydrogenase (PDH) was found to be a crucial mediator of oncogene-induced senescence (OIS) by BRAFV600E, which was accompanied by increased pyruvate oxidation and mitochondrial oxidative phosphorylation [11].”
BackgroundTargeting Cancer Metabolism and Current Anti-Cancer Drugs
Sukjoi, W., Ngamkham, J., Attwood, P. V., & Jitrapakdee, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_2 · Cited by 25
Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma
Inoue, J., Kishikawa, M., Tsuda, H., Nakajima, Y., Asakage, T., & Inazawa, J. (2021) · Cancer Science · doi:10.1111/cas.14938 · Cited by 24
Time-resolved proteomic analyses of senescence highlight metabolic rewiring of mitochondria
Kim, J. Y., Atanassov, I., Dethloff, F., Kroczek, L., & Langer, T. (2023) · Life Science Alliance · doi:10.26508/lsa.202302127 · Cited by 25
“Increased activity of the pyruvate dehydrogenase complex, which converts pyruvate to acetyl-CoA in mitochondria, enhances OXPHOS activity and is a rate-limiting factor to drive oncogene-induced senescence (14).”
BackgroundWang, Y., Xu, Q., Sack, L. M., Kang, C., & Elledge, S. J. (2016) · Genes & Development · doi:10.1101/gad.271445.115 · Cited by 24
“Mechanistic study revealed that oncogenic senescence triggers such as Raf activation induces the activation of mitochondrial gatekeeper pyruvate dehydrogenase PDH1 [30].”
BackgroundWang, C., Tanizawa, H., Hill, C., Havas, A. P., Zhang, Q., Liao, L., Xue, H., Lei, X., Wang, L., Nie, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49745-5 · Cited by 23
“Despite HK2 ’ s functional importance in senescence 17,18 , its regulation in senescence remains poorly understood.”
Shen, H., Ying, Y., Ma, X., Xie, H., Chen, S., Sun, J., Liu, Z., Wen, C., Yang, Z., Wang, X., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01151-w · Cited by 23
“In melanoma, PDK1 was revealed to facilitate resistance of targeted BRAF inhibition through mediating oncogene-induced senescence induced by BRAF [50].”
BackgroundNiezen, S., Connelly, M. A., Hirsch, C. H., Kizer, J. R., Benítez, M. R., Minchenberg, S. B., Pérez-Matos, M. C., Jiang, Z. G., & Mukamal, K. J. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029960 · Cited by 23
Shestov, A. A., Mancuso, A., Lee, S., Guo, L., NELSON, D. S., Roman, J. C., Henry, P., Leeper, D. B., Blair, I. A., & Glickson, J. D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.701862 · Cited by 25
“Recent work (43) has demonstrated that BRAF V600E mutated melanoma cells exhibit increased pyruvate entry through the activated PDH complex.”
BackgroundOrganismal Aging and Oxidants beyond Macromolecules Damage
Clement, M., & Luo, L. (2020) · PROTEOMICS · doi:10.1002/pmic.201800400 · Cited by 23
Rhynchophylline promotes stem cell autonomous metabolic homeostasis
Kaneko, Y., Coats, A. B., Tuazon, J. P., Jo, M., & Borlongan, C. V. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2019.12.008 · Cited by 22
Wen, Z., Xia, G., Liang, C., Wang, X., Huang, J., Zhang, L., Shan, D., Song, W. C., & Cao, X. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0141 · Cited by 26
Mitochondrial metabolic remodeling in response to genetic and environmental perturbations
Hollinshead, K. E. R., & Tennant, D. A. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1334 · Cited by 24
“These phenotypes could be designed to avoid activation of cellular senescence pathways in hypoxia, as suppression of the PDC by oncogene activation has recently been shown as critical in suppressing oncogene-induced senescence (OIS).(27) Indeed, further evidence of the use of metabolic remodeling in hypoxia to avoid R…”
BackgroundE2F1 Suppresses Oxidative Metabolism and Endothelial Differentiation of Bone Marrow Progenitor Cells
Xu, S., Tao, J., Liu, Y., Zhang, E., Boriboun, C., Zhou, J., Sun, T., Cheng, M., Huang, K., Shi, J., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311814 · Cited by 23
Metabolic rewiring directs melanoma immunology
Sun, N., Tian, Y., Chen, Y., Guo, W., & Li, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909580 · Cited by 25
Saleh, T., Khasawneh, A. I., Himsawi, N. M., Abu-Raideh, J. A., Ejeilat, V., Elshazly, A. M., & Gewirtz, D. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415512 · Cited by 24
“Furthermore, senescent cells preserve their active metabolic status, albeit dysregulated, as evidenced by a remarkable increase in oxygen consumption rate and mitochondrial oxidative metabolism in OIS cells as opposed to quiescent cells which typically have reduced metabolic rates [41].”
BackgroundWen, Y., Li, S., Zhao, F., Wang, J., Liu, X., Hu, J., Bao, G., & Luo, Y. (2022) · Animals · doi:10.3390/ani12050583 · Cited by 24
“Because the redox state of the intracellular NAD is a key factor for regulating glucose metabolism [60], a high NADH/NAD+ content indicates the up-regulation of OXPHOS, and the increase in NAD+ activity can also enhance mitochondrial function and increase ATP production [61].”
BackgroundInfluentialKamranian, H., Asoudeh, H., Kamrani, R., Taheri, F., Hayes, A. W., Gholami, M., Alavi, A., & Motaghinejad, M. (2023) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2023.2202785 · Cited by 23
Ramirez, A. K., Lynes, M. D., Shamsi, F., Xue, R., Tseng, Y., Kahn, C. R., Kasif, S., & Dreyfuss, J. M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.065 · Cited by 21
“Prior studies have shown the potential of connecting extracellular measurements with FBA (Aurich et al., 2015; Fan et al., 2013, 2014; Frezza et al., 2011; Kaplon et al., 2013; Mo et Cell Rep. Author manuscript; available in PMC 2018 March 07.”
BackgroundSenescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 24
“Senescent cells acquire marked changes in mitochondrial and lysosomal numbers, morphology and function, display altered redox balance, rewired glycolytic/OXPHOS states, increased dependence on metabolites such as NAD + and a-ketoglutarate, and broad changes in lipid metabolism 80,81,82 .”
Wang, G., Liu, K., Li, Y., Yi, W., Yang, Y., Zhao, D., Fan, C., Yang, H., Geng, T., Xing, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113983 · Cited by 20
“Pyruvate, which is the anionic form of a simple alpha-keto acid, plays a key role in intermediary metabolism as a product of glycolysis and as the starting substrate for the tricarboxylic acid (TCA) cycle [6].”
BackgroundWang, J., Kumaran, S., Zhou, J., Nemeria, N. S., Tao, H., Kakalis, L. T., Park, Y., Birkaya, B. G., Patel, M. S., & Jordan, F. (2014) · Biochemistry · doi:10.1021/bi5013113 · Cited by 21
Kaplon, J., Cornelia, H.-H., Gao, L. Y., Meissl, K., Verdegaal, E. M. E., van der Burg, S. H., van Doorn, R., & Peeper, D. S. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12248 · Cited by 21
Self-citationSynthetic lethality: emerging targets and opportunities in melanoma
Thompson, N., Adams, D. J., & Ranzani, M. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12573 · Cited by 22
“PDK1 was also shown to have role in mediating oncogene-induced senescence in untransformed cells, causing cell cycle arrest upon the induction of BRAFV600E expression (Kaplon et al., 2013; Scortegagna et al., 2014).”
Venkatesh, S., & Suzuki, C. K. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.10.004 · Cited by 21
Cytokine-induced senescence for cancer surveillance
Wieder, T., Brenner, E., Braumüller, H., Bischof, O., & Röcken, M. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9667-z · Cited by 20
“By regulating the mitochondrial gate keeper pyruvate dehydrogenase, senescent cells make enhanced use of pyruvate in the tricarboxylic acid cycle [74].”
BackgroundZhang, J., Lou, X., Zellmer, L., Liu, S., Xu, N., & JoshuaLiao, D. (2014) · Oncoscience · doi:10.18632/oncoscience.83 · Cited by 19
“Actually, induced senescence has also been shown to be reversible upon withdrawal of the inducer [72,74-76], although spontaneous senescence should be irreversible.”
BackgroundMitochondria-driven elimination of cancer and senescent cells
Hubáčková, S., Novais, S. M., Davidová, E., Neužil, J., & Rohlena, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0256 · Cited by 20
Shroads, A. L., Coats, B. S., McDonough, C. W., Langaee, T. Y., & Stacpoole, P. W. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.371 · Cited by 19
“The PDC–PDK axis has been the focus of considerable multidisciplinary research, not only because of its critical role in cellular bioenergetics, but also because of its emerging presence as a therapeutic target for many congenital and acquired disorders in which cellular fuel metabolism is perturbed.(3) Dichloroacetat…”
BackgroundTargeting Mitochondria for Cancer Treatment – Two Types of Mitochondrial Dysfunction
Pokorný, J., Pokorný, J., Kobilková, J., Jandová, A., Vrba, J., & Vrba, J. (2014) · Prague Medical Report · doi:10.14712/23362936.2014.41 · Cited by 23
“Induced OIS keeps a normal function of PDH and abrogated OIS results in the mitochondrial dysfunction by inhibition of the pyruvate transfer (Kaplon et al., 2013; Olenchock and Vander Heiden, 2013).”
BackgroundPyruvate as a Pivot Point for Oncogene-Induced Senescence
Olenchock, B. A., & Heiden, M. G. V. (2013) · Cell · doi:10.1016/j.cell.2013.06.001 · Cited by 20
Advances in hydrogel systems for bone regeneration: trends, innovations, and prospects
Han, Y., Liu, J., Hu, C., Wang, Y., & He, C. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb02041g · Cited by 18
Mitochondrial metabolism and epigenetic crosstalk drive SASP
Martini, H., Birch, J., Marques, F. M., Victorelli, S. G., Lagnado, A. B., Pirius, N., Franco, A. C., Lee, G., Han, Y., Rowsey, J. L., et al. (2026) · Nature · doi:10.1038/s41586-026-10791-2 · Cited by 24
FOXM1 regulates glycolysis in nasopharyngeal carcinoma cells through PDK1
Yang, Q. F., Wu, F., Zhang, Y., & Wang, R. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17413 · Cited by 18
Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer
Cortellino, S., D’Angelo, M., Quintiliani, M., & Giordano, A. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31417 · Cited by 20
“Altered PDK1 or PDP2 activity and expression in tumor cells inhibit PDH, thereby promoting tumor growth by increasing glycolytic intermediates that support anabolic pathways (Stacpoole, 2017; Woolbright et al., 2019).”
Liao, G.-Y., Lee, M., Fan, J.-J., Hsiao, P., Lee, C.-S., Su, S.-Y., Hwang, J.-J., & Ke, F. (2019) · Biology Open · doi:10.1242/bio.038257 · Cited by 20
“Moreover, increasing evidence implicates that cellular metabolism correlated with the balance of mitochondrial metabolites plays a role in cellular senescence (Borradaile and Pickering, 2009; Hashizume et al., 2015; Ho et al., 2009; Jiang et al., 2013; Kaplon et al., 2013; Lee et al., 2012; van der Veer et al., 2007).”
AKT but not MYC promotes reactive oxygen species-mediated cell death in oxidative culture
(2020) · doi:10.1242/jcs.239277 · Cited by 18
Liu, J., Zhang, M., & Qu, Y.-Q. (2020) · International Journal of COPD · doi:10.2147/copd.s265728 · Cited by 18
Abildgaard, C., Rizza, S., Christiansen, H., Schmidt, S., Dahl, C., Abdul-Al, A., Christensen, A., Filomeni, G., & Guldberg, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-83796-8 · Cited by 20
Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions
Saleh, T., & Carpenter, V. J. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000361 · Cited by 17
“The enduring expression of mutant BRAF ( BRAF -V600E) in melanocytes induces senescence marked by growth arrest, p16 INK4a expression, and SA-b -gal upregulation (Michaloglou et al., 2005; Kaplon et al., 2013).”
Ripk3 signaling regulates HSCs during stress and represses radiation-induced leukemia in mice
Zhang, L., Luo, H., Ni, H., Liu, S., Xing, H., Zhang, J., Sellin, M., Breslin, P., Wei, W., Denning, M. F., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.04.009 · Cited by 17
“Pdc has been described as a key mediator of oncogene-induced senescence, a vital pathophysiological mechanism that protects against cancer (Kaplon et al., 2013).”
BackgroundDivergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer
Kudo, K., Nomura, M., Sakamoto, Y., Ito, S., Morita, M., Kawai, M., Yamashita, Y., Ito, K., Yamada, H., Shima, H., et al. (2020) · FEBS Letters · doi:10.1002/1873-3468.13736 · Cited by 18
Lin, L., Zhang, Y., Qian, W., Liu, Y., Zhang, Y., Lin, F., Liu, C., Lu, G., Sun, D., Guo, X., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119767119 · Cited by 18
“Since the connection between mitochondria and BRAF inhibitor resistance has been widely observed (27, 28), this result actually validated the function of LINEAGE.”
ResultA Brake for B Cell Proliferation
Jellusova, J., & Rickert, R. C. (2017) · BioEssays · doi:10.1002/bies.201700079 · Cited by 18
Divergent mechanisms of metabolic dysfunction drive fibroblast and T-cell senescence
Callender, L. A., Carroll, E. C., Bober, E. A., & Henson, S. M. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.06.001 · Cited by 18
“(OXPHOS) by increasing the expression of the mitochondrial enzyme pyruvate dehydrogenase (PDH) (Figure 1) (Kaplon et al. 2013;Aird and Zhang, 2014).”
Cellular senescence in neuroblastoma
Zanotti, S., Decaesteker, B., Vanhauwaert, S., Wilde, B. D., Vos, W. H. D., & Speleman, F. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01755-0 · Cited by 18
“This subsequently drives an increase in pyruvate uptake during the tricarboxylic acid cycle which triggers increased respiration and redox stress and eventually leads to OIS activation [38].”
BackgroundQin, J., Cao, M., Hu, X., Tan, W., Ma, B., Cao, Y., Chen, Z., Li, Q., & Hu, G. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115057 · Cited by 16
Metadata
- Authors
- Kaplon, J., Zheng, L., Meissl, K., Chaneton, B., Selivanov, V. A., Mackay, G., van der Burg, S. H., Verdegaal, E. M. E., Cascante, M., Shlomi, T., Gottlieb, E., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Cancer Research UK Scotland Institute (GB)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gottlieb, Eyal
- Peeper, Daniel S.
- ORCID
- Venue
- Nature
- Published
- 2013-05-19
- Volume
- 498
- Issue
- 7452
- Pages
- 109-112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2164524616
- Cited by
- 633
- References
- 33
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 38 · 2023: 49 · 2022: 51 · 2021: 55 · 2020: 47 · 2019: 43 · 2018: 38 · 2017: 58 · 2016: 59 · 2015: 56 · 2014: 56 · 2013: 18
- FWCI
- 43.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Cancer Research UK
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- oncogene-induced senescence, pyruvate dehydrogenase, pyruvate dehydrogenase kinase 1, PDP2, BRAF V600E mutation, melanoma, glucose oxidation, glycolysis, oxidative phosphorylation, mitochondrial metabolism, senescence-associated secretory phenotype, senescence-associated heterochromatin foci, senescence-associated DNA damage
- MeSH terms
- Pyruvate Dehydrogenase Acetyl-Transferring Kinase, Animals, Cell Line, Citric Acid Cycle, Disease Models, Animal, Enzyme Activation, Glycolysis, Humans, Melanoma, Mitochondria, Oncogenes, Oxidative Phosphorylation, Pyruvate Dehydrogenase Complex, Pyruvate Dehydrogenase (Lipoamide)-Phosphatase, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Cellular Senescence, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins B-raf, Mice, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.